Back to search
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory or Recurrent Solid Tumors, Excluding CNS Tumors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory or Recurrent Solid Tumors, Excluding CNS Tumors trials you may qualify forThis is a phase 1, open-label, dose escalation study to evaluate the safety, pharmacokinetics, and antitumor activity of pixantrone in pediatric patients with r…
This is a Phase 1 study of eribulin mesylate in pediatric participants with recurrent or refractory solid tumors (excluding CNS), including lymphomas. Eribulin…
This trial will be the first study of axitinib in children and adolescents. The primary objective of this Phase 1 trial is to determine a maximum tolerated dose…